SEC Stock Data Quick Answer ADMA BIOLOGICS, INC. reported Revenue (ASC 606) of $510.17 million for fiscal year 2025. ADMA BIOLOGICS, INC. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $510.17M +19.6% 2024 $426.45M +65.2% 2023 $258.21M +67.6% 2022 $154.08M +90.4% 2021 $80.94M +91.7% 2020 $42.22M — Quarterly Revenue (ASC 606) Quarter … Read more
Quick Answer ADMA BIOLOGICS, INC. reported Total Revenue of $510.17 million for fiscal year 2025. ADMA BIOLOGICS, INC. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $510.17M +19.6% 2024 $426.45M +65.2% 2023 $258.21M +67.6% 2022 $154.08M +90.4% 2021 $80.94M +91.7% 2020 $42.22M +43.9% 2019 $29.35M +72.8% 2018 $16.99M -25.4% 2017 $22.76M … Read more
Quick Answer ADMA BIOLOGICS, INC. reported Total Revenue of $510.17 million for fiscal year 2025. ADMA BIOLOGICS, INC. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $510.17M+19.6% $426.45M+65.2% $258.21M+67.6% $154.08M+90.4% $80.94M+91.7% $42.22M+43.9% Revenue (ASC 606) $510.17M+19.6% $426.45M+65.2% $258.21M+67.6% $154.08M+90.4% $80.94M+91.7% $42.22M Net Income $146.93M-25.7% $197.67M+800.0% -$28.24M+57.2% -$65.90M+8.0% -$71.65M+5.4% -$75.75M-56.9% … Read more
Quick Answer Archer-Daniels-Midland Co reported Gross Profit of $5.03 billion for fiscal year 2025. Archer-Daniels-Midland Co Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $5.03B -12.9% 2024 $5.78B -23.1% 2023 $7.51B -0.8% 2022 $7.57B +26.4% 2021 $5.99B +34.4% 2020 $4.45B +7.4% 2019 $4.15B -0.8% 2018 $4.18B +18.8% 2017 $3.52B -2.8% 2016 … Read more
Quick Answer Archer-Daniels-Midland Co reported Stockholders Equity of $22.74 billion for fiscal year 2025. Archer-Daniels-Midland Co Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $22.74B +2.5% 2024 $22.18B -8.1% 2023 $24.14B -0.7% 2022 $24.32B +8.0% 2021 $22.51B +12.4% 2020 $20.02B +4.1% 2019 $19.23B +1.2% 2018 $19.00B +3.7% 2017 $18.32B +6.6% 2016 … Read more
Quick Answer Archer-Daniels-Midland Co reported Long-Term Debt of $6.61 billion for fiscal year 2025. Archer-Daniels-Midland Co Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $6.61B -12.8% 2024 $7.58B -8.2% 2023 $8.26B +6.8% 2022 $7.74B -3.4% 2021 $8.01B +1.6% 2020 $7.88B +2.8% 2019 $7.67B -0.3% 2018 $7.70B +16.2% 2017 $6.62B +1.8% 2016 … Read more
Quick Answer Archer-Daniels-Midland Co reported Cash and Equivalents of $1.01 billion for fiscal year 2025. Archer-Daniels-Midland Co Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $1.01B +66.1% 2024 $611.00M -55.3% 2023 $1.37B +31.9% 2022 $1.04B +10.0% 2021 $943.00M +41.6% 2020 $666.00M -21.8% 2019 $852.00M -57.3% 2018 $2.00B +148.4% 2017 … Read more
Quick Answer Archer-Daniels-Midland Co reported Total Assets of $52.39 billion for fiscal year 2025. Archer-Daniels-Midland Co Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $52.39B -1.7% 2024 $53.27B -2.5% 2023 $54.63B -8.6% 2022 $59.77B +6.5% 2021 $56.14B +12.9% 2020 $49.72B +13.0% 2019 $44.00B +7.7% 2018 $40.83B +2.2% 2017 $39.96B +0.5% 2016 … Read more
Quick Answer Archer-Daniels-Midland Co reported Diluted EPS of $2.23 per share for fiscal year 2025. Archer-Daniels-Midland Co Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $2.23 -38.9% 2024 $3.65 -43.2% 2023 $6.43 -16.6% 2022 $7.71 +61.0% 2021 $4.79 +52.1% 2020 $3.15 +29.1% 2019 $2.44 -23.5% 2018 $3.19 +14.3% 2017 $2.79 +29.2% … Read more
Quick Answer Archer-Daniels-Midland Co reported Net Income of $1.08 billion for fiscal year 2025. Archer-Daniels-Midland Co Net Income — Annual History Fiscal Year Net Income YoY Change 2025 $1.08B -40.1% 2024 $1.80B -48.3% 2023 $3.48B -19.7% 2022 $4.34B +60.2% 2021 $2.71B +52.9% 2020 $1.77B +28.5% 2019 $1.38B -23.8% 2018 $1.81B +13.5% 2017 $1.59B +24.7% 2016 … Read more